To the Editor: Drs. Crist and Kun gave an excellent overview of the status of pediatric oncology in their review article (Feb. 14 issue).1 Their statement concerning the role of radiation therapy in patients with neuroblastoma should, however, be modified. The authors stated that children with lymph-node involvement benefit from regional irradiation. They referred to a paper in press, which has since appeared,2 that deals with children over one year of age in Pediatric Oncology Group Stage C. Hence, the statement does not apply to patients under one year of age. Moreover, Stage C in the Pediatric Oncology Group system. .
ASJC Scopus subject areas